223 related articles for article (PubMed ID: 23422663)
1. Smoking exacerbates amyloid pathology in a mouse model of Alzheimer's disease.
Moreno-Gonzalez I; Estrada LD; Sanchez-Mejias E; Soto C
Nat Commun; 2013; 4():1495. PubMed ID: 23422663
[TBL] [Abstract][Full Text] [Related]
2. Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model.
Ghosh S; Wu MD; Shaftel SS; Kyrkanides S; LaFerla FM; Olschowka JA; O'Banion MK
J Neurosci; 2013 Mar; 33(11):5053-64. PubMed ID: 23486975
[TBL] [Abstract][Full Text] [Related]
3. GPR84 deficiency reduces microgliosis, but accelerates dendritic degeneration and cognitive decline in a mouse model of Alzheimer's disease.
Audoy-Rémus J; Bozoyan L; Dumas A; Filali M; Lecours C; Lacroix S; Rivest S; Tremblay ME; Vallières L
Brain Behav Immun; 2015 May; 46():112-20. PubMed ID: 25637481
[TBL] [Abstract][Full Text] [Related]
4. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
Saul A; Sprenger F; Bayer TA; Wirths O
Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
[TBL] [Abstract][Full Text] [Related]
5. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
[TBL] [Abstract][Full Text] [Related]
6. Conditional inactivation of nicastrin restricts amyloid deposition in an Alzheimer's disease mouse model.
Sesele K; Thanopoulou K; Paouri E; Tsefou E; Klinakis A; Georgopoulos S
Aging Cell; 2013 Dec; 12(6):1032-40. PubMed ID: 23826707
[TBL] [Abstract][Full Text] [Related]
7. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of apolipoprotein E, amyloid precursor protein and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue.
Martins RN; Taddei K; Kendall C; Evin G; Bates KA; Harvey AR
Neuroscience; 2001; 106(3):557-69. PubMed ID: 11591456
[TBL] [Abstract][Full Text] [Related]
9. SorLA deficiency dissects amyloid pathology from tau and cholinergic neurodegeneration in a mouse model of Alzheimer's disease.
Capsoni S; Carlo AS; Vignone D; Amato G; Criscuolo C; Willnow TE; Cattaneo A
J Alzheimers Dis; 2013; 33(2):357-71. PubMed ID: 22986780
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
Götz J; Schild A; Hoerndli F; Pennanen L
Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
[TBL] [Abstract][Full Text] [Related]
11. A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss.
Cohen RM; Rezai-Zadeh K; Weitz TM; Rentsendorj A; Gate D; Spivak I; Bholat Y; Vasilevko V; Glabe CG; Breunig JJ; Rakic P; Davtyan H; Agadjanyan MG; Kepe V; Barrio JR; Bannykh S; Szekely CA; Pechnick RN; Town T
J Neurosci; 2013 Apr; 33(15):6245-56. PubMed ID: 23575824
[TBL] [Abstract][Full Text] [Related]
12. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
[TBL] [Abstract][Full Text] [Related]
14. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
[TBL] [Abstract][Full Text] [Related]
15. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer's disease.
Park J; Wetzel I; Marriott I; Dréau D; D'Avanzo C; Kim DY; Tanzi RE; Cho H
Nat Neurosci; 2018 Jul; 21(7):941-951. PubMed ID: 29950669
[TBL] [Abstract][Full Text] [Related]
16. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology.
Lee SH; Meilandt WJ; Xie L; Gandham VD; Ngu H; Barck KH; Rezzonico MG; Imperio J; Lalehzadeh G; Huntley MA; Stark KL; Foreman O; Carano RAD; Friedman BA; Sheng M; Easton A; Bohlen CJ; Hansen DV
Neuron; 2021 Apr; 109(8):1283-1301.e6. PubMed ID: 33675684
[TBL] [Abstract][Full Text] [Related]
17. The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS1 transgenic mouse model of Alzheimer's disease.
Zhu S; Wang J; Zhang Y; He J; Kong J; Wang JF; Li XM
CNS Neurosci Ther; 2017 Apr; 23(4):310-320. PubMed ID: 28191738
[TBL] [Abstract][Full Text] [Related]
18. The age-related slow increase in amyloid pathology in APP.V717I mice activates microglia, but does not alter hippocampal neurogenesis.
Hoeijmakers L; Meerhoff GF; de Vries JW; Ruigrok SR; van Dam AM; van Leuven F; Korosi A; Lucassen PJ
Neurobiol Aging; 2018 Jan; 61():112-123. PubMed ID: 29059594
[TBL] [Abstract][Full Text] [Related]
19. Cigarette smoking accelerated brain aging and induced pre-Alzheimer-like neuropathology in rats.
Ho YS; Yang X; Yeung SC; Chiu K; Lau CF; Tsang AW; Mak JC; Chang RC
PLoS One; 2012; 7(5):e36752. PubMed ID: 22606286
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia.
Hüttenrauch M; Ogorek I; Klafki H; Otto M; Stadelmann C; Weggen S; Wiltfang J; Wirths O
Acta Neuropathol Commun; 2018 Oct; 6(1):108. PubMed ID: 30340518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
